Exact Mass: 403.2172
Exact Mass Matches: 403.2172
Found 110 metabolites which its exact mass value is equals to given mass value 403.2172,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3,4-Dihydroxy-tamoxifen
4-[(1E)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]benzene-1,2-diol
3,4-Dihydroxy-tamoxifen is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)
metergoline
benzyl N-({6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl}methyl)carbamate
4-phenyl-9-(3-phenyl-acryloyl)-1,5,9-triaza-cyclotridec-10-en-2-one|Neoperiphyllin|Neoperiphylline
4-phenyl-9-(3-phenyl-acryloyl)-1,5,9-triaza-cyclotridec-10-en-2-one|Neoperiphyllin|Neoperiphylline
Metergoline
Metergoline phenylmethyl ester
An ergoline alkaloid that is the N-benzyloxycarbonyl derivative of lysergamine. A 5-HT2 antagonist. Also 5-HT1 antagonist and 5-HT1D ligand. Has moderate affinity for 5-HT6 and high affinity for 5-HT7. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CB - Prolactine inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist relative retention time with respect to 9-anthracene Carboxylic Acid is 0.923 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.918 Metergoline is a serotonin (5-HT) receptor and dopamine receptors antagonist, with pKis of 8.64, 8.75 and 8.75 for 5-HT2A, 5-HT2B and 5-HT2C, respectively. Metergoline is a high-affinity ligand for the h5-HT7 receptor, with a Ki of 16 nM. Metergoline is also a reversible neural Na+ channels inhibitor. Metergoline is commonly used for the research of seasonal affective disorder, prolactin hormone regulation[1][2][3].
Ala Ala Arg Ser
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid
Ala Ala Ser Arg
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid
Ala Gly Arg Thr
(2S,3R)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid
Ala Gly Thr Arg
(2S)-2-[(2S,3R)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid
Ala Arg Ala Ser
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]propanamido]-3-hydroxypropanoic acid
Ala Arg Gly Thr
(2S,3R)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]acetamido}-3-hydroxybutanoic acid
Ala Arg Ser Ala
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]propanoic acid
Ala Arg Thr Gly
2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]acetic acid
Ala Ser Ala Arg
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]propanamido]-5-carbamimidamidopentanoic acid
Ala Ser Arg Ala
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]propanoic acid
Ala Thr Gly Arg
(2S)-2-{2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]acetamido}-5-carbamimidamidopentanoic acid
Ala Thr Arg Gly
2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]acetic acid
Gly Ala Arg Thr
(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid
Gly Ala Thr Arg
(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid
Gly Arg Ala Thr
(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]propanamido]-3-hydroxybutanoic acid
Gly Arg Thr Ala
(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-hydroxybutanamido]propanoic acid
Gly Thr Ala Arg
(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]propanamido]-5-carbamimidamidopentanoic acid
Gly Thr Arg Ala
(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-5-carbamimidamidopentanamido]propanoic acid
Arg Ala Ala Ser
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]propanamido]-3-hydroxypropanoic acid
Arg Ala Gly Thr
(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]acetamido}-3-hydroxybutanoic acid
Arg Ala Ser Ala
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-hydroxypropanamido]propanoic acid
Arg Ala Thr Gly
2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-hydroxybutanamido]acetic acid
Arg Gly Ala Thr
(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}propanamido]-3-hydroxybutanoic acid
Arg Gly Thr Ala
(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-hydroxybutanamido]propanoic acid
Arg Ser Ala Ala
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]propanamido]propanoic acid
Arg Thr Ala Gly
2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]propanamido]acetic acid
Arg Thr Gly Ala
(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]acetamido}propanoic acid
Ser Ala Ala Arg
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]propanamido]-5-carbamimidamidopentanoic acid
Ser Ala Arg Ala
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-5-carbamimidamidopentanamido]propanoic acid
Ser Arg Ala Ala
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]propanamido]propanoic acid
Thr Ala Gly Arg
(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]acetamido}-5-carbamimidamidopentanoic acid
Thr Ala Arg Gly
2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-5-carbamimidamidopentanamido]acetic acid
Thr Gly Ala Arg
(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}propanamido]-5-carbamimidamidopentanoic acid
Thr Gly Arg Ala
(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-5-carbamimidamidopentanamido]propanoic acid
Thr Arg Ala Gly
2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]propanamido]acetic acid
Thr Arg Gly Ala
(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]acetamido}propanoic acid
ACETIC ACID (2S,3S)-3-DIBENZYLAMINO-2-HYDROXY-4-PHENYLBUTYL ESTER
ACETIC ACID (2S,3S)-3-DIBENZYLAMINO-2-HYDROXY-4-PHENYLBUTYL ESTER
ACETIC ACID (2R,3S)-3-DIBENZYLAMINO-2-HYDROXY-4-PHENYLBUTYL ESTER
ACETIC ACID (2R,3S)-3-DIBENZYLAMINO-2-HYDROXY-4-PHENYLBUTYL ESTER
Azepino[4,5-b]indole-5-carboxylic acid, 1,2,3,6-tetrahydro-1,1-dimethyl-8-[methyl(phenylmethyl)amino]-, ethyl ester
Azepino[4,5-b]indole-5-carboxylic acid, 1,2,3,6-tetrahydro-1,1-dimethyl-8-[methyl(phenylmethyl)amino]-, ethyl ester
1H-Indole-1-carboxylic acid, 3-(1-cyano-1-methylethyl)-6-[methyl(phenylmethyl)amino]-, 1,1-dimethylethyl ester
1H-Indole-1-carboxylic acid, 3-(1-cyano-1-methylethyl)-6-[methyl(phenylmethyl)amino]-, 1,1-dimethylethyl ester
2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate
2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate
Diponium bromide
Diponium bromide
C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
Amotriphene
Amotriphene
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
N-((2-Methoxypyridin-4-yl)methyl)-1-(1-(naphthalen-1-yl)ethyl)piperidine-4-carboxamide
N-((2-Methoxypyridin-4-yl)methyl)-1-(1-(naphthalen-1-yl)ethyl)piperidine-4-carboxamide
(R)-N-((2-Methoxypyridin-4-yl)methyl)-1-(1-(naphthalen-1-yl)ethyl)piperidine-4-carboxamide
(R)-N-((2-Methoxypyridin-4-yl)methyl)-1-(1-(naphthalen-1-yl)ethyl)piperidine-4-carboxamide
Methyl 4-{[({[(2R,5S)-5-{[(2S)-2-(aminomethyl)pyrrolidin-1-YL]carbonyl}pyrrolidin-2-YL]methyl}amino)carbonyl]amino}benzoate
Methyl 4-{[({[(2R,5S)-5-{[(2S)-2-(aminomethyl)pyrrolidin-1-YL]carbonyl}pyrrolidin-2-YL]methyl}amino)carbonyl]amino}benzoate
2-(3,5-dimethyl-1-pyrazolyl)-N-[[3-(4-fluorophenyl)-1-(4-methylphenyl)-4-pyrazolyl]methyl]ethanamine
2-(3,5-dimethyl-1-pyrazolyl)-N-[[3-(4-fluorophenyl)-1-(4-methylphenyl)-4-pyrazolyl]methyl]ethanamine
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(2-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclopropylmethyl)acetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclopropylmethyl)acetamide
(3aS,4R,9bR)-4-(hydroxymethyl)-5-methyl-8-(2-phenylethynyl)-N-propan-2-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
(3aS,4R,9bR)-4-(hydroxymethyl)-5-methyl-8-(2-phenylethynyl)-N-propan-2-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-(2-phenylethynyl)-N-propan-2-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-(2-phenylethynyl)-N-propan-2-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
4-[4-[(1S,5R)-3-[cyclobutyl(oxo)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
4-[4-[(1S,5R)-3-[cyclobutyl(oxo)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
N-[4-(2,3,9,9-tetramethyl-7-oxo-6,6a,8,10-tetrahydro-5H-benzo[b][1,4]benzodiazepin-6-yl)phenyl]acetamide
N-[4-(2,3,9,9-tetramethyl-7-oxo-6,6a,8,10-tetrahydro-5H-benzo[b][1,4]benzodiazepin-6-yl)phenyl]acetamide
1-(8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,12-dien-1-yl)-3-phenylprop-2-en-1-one
1-(8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,12-dien-1-yl)-3-phenylprop-2-en-1-one
(2e)-1-[(6r,10e)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one
(2e)-1-[(6r,10e)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one
n-[(2r,5s)-2,6-dihydroxy-5-[(3-hydroxyquinolin-2-yl)formamido]hexyl]-3-methylbutanimidic acid
n-[(2r,5s)-2,6-dihydroxy-5-[(3-hydroxyquinolin-2-yl)formamido]hexyl]-3-methylbutanimidic acid
n-{2,6-dihydroxy-5-[(3-hydroxyquinolin-2-yl)formamido]hexyl}-3-methylbutanimidic acid
n-{2,6-dihydroxy-5-[(3-hydroxyquinolin-2-yl)formamido]hexyl}-3-methylbutanimidic acid
(2e)-1-[(6s,12z)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,12-dien-1-yl]-3-phenylprop-2-en-1-one
(2e)-1-[(6s,12z)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,12-dien-1-yl]-3-phenylprop-2-en-1-one
9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one
9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one
(2z)-1-[(6r,10e)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one
(2z)-1-[(6r,10e)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one
(7r,13r)-9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one
(7r,13r)-9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one
[(1s)-2-(7-hydroxy-1h-indol-3-yl)-1-{[(1e)-2-(1h-indol-2-yl)ethenyl]-c-hydroxycarbonimidoyl}ethyl]trimethylazanium
[(1s)-2-(7-hydroxy-1h-indol-3-yl)-1-{[(1e)-2-(1h-indol-2-yl)ethenyl]-c-hydroxycarbonimidoyl}ethyl]trimethylazanium
(2e)-1-[(6s,10z)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one
(2e)-1-[(6s,10z)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one
(7s,13r)-9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one
(7s,13r)-9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one
1-(8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl)-3-phenylprop-2-en-1-one
1-(8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl)-3-phenylprop-2-en-1-one
